Publication:
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature

dc.contributor.authorRojas, Monica
dc.contributor.authorLución, Maria
dc.contributor.authorBecker, Ricardo
dc.contributor.authorLuevanos, Antonio
dc.contributor.authorGutierrez, Ivan
dc.contributor.authorEstripeaut, Dora
dc.contributor.authorSchilling Redlich, Andrea
dc.contributor.authorWebster, Jessica
dc.contributor.authorPerez, Maria
dc.contributor.authorHirata, Luciana
dc.contributor.authorOrengo, Juan
dc.contributor.authorParellada, Cintia
dc.date.accessioned2026-08-25T21:54:06Z
dc.date.available2026-08-25T21:54:06Z
dc.date.issued2025
dc.description.abstractThis review aimed to characterize adolescent vaccination schedules in publicly funded national immunization programs in Latin America and the Caribbean. The initial review identified vaccine type, target age and gender, dose schedule, and vaccination coverage rate (VCR) across 50 countries/territories in the region. A systematic review from January 2010-October 2023 was then conducted to identify primary data collection studies reporting VCRs. Overall, 42 webpages and 23 primary studies were identified. Among 47 countries/territories with ≥1 vaccine for adolescent immunization, human papillomavirus (HPV) vaccine was included in 45, tetanus component vaccines in 43, and meningococcal vaccines in 10. Catch-up vaccination for hepatitis B in 17, and yellow fever in all 13 endemic countries/territories. VCRs were primarily available for HPV. The findings of this review underscore the need to prioritize adolescent vaccination, improve accessibility, and strengthen tracking infrastructure to ensure comprehensive protection of this age group across the region.
dc.description.versionVersión Publicada
dc.identifier.citationRojas M, Florencia Lución M, Becker Feijó R, Luevanos A, Gutierrez Tobar IF, Estripeaut D, Schilling A, Webster J, Eugenia Perez M, Hirata L, Orengo JC, Irene Parellada C. Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature. Hum Vaccin Immunother. 2025 Dec;21(1):2528403. doi: 10.1080/21645515.2025.2528403
dc.identifier.doihttps://doi.org/10.1080/21645515.2025.2528403
dc.identifier.urihttps://hdl.handle.net/11447/11037
dc.language.isoen
dc.subjectAdolescent
dc.subjectLatin America and Caribbean
dc.subjectImmunization
dc.subjectVaccination coverage
dc.subjectVaccine uptake
dc.subjectVaccines
dc.titleCharacterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceHuman vaccines & immunotherapeutics
dspace.entity.typePublication
relation.isAuthorOfPublicationc4b84d1b-640f-4b15-94a2-03181f398c50
relation.isAuthorOfPublication.latestForDiscoveryc4b84d1b-640f-4b15-94a2-03181f398c50

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean A review of the literature.pdf
Size:
3 MB
Format:
Adobe Portable Document Format
Description:
Texto Completo
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description: